Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development

Reproductive Toxicology

Volumn 28, Issue 2, 2009, Pages 239-244

  Burdan, Franciszek ^a   Szumilo, Justyna ^a   Klepacz, Robert ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Maternal health; Maternal toxicity; NSAID; Pregnancy; Prenatal toxicity

Indexed keywords

IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; TOLMETIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; FETUS WEIGHT; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; MATERNAL DISEASE; NONHUMAN; OSSIFICATION; PLACENTA WEIGHT; PRENATAL DEVELOPMENT; PROGENY; RAT; RISK ASSESSMENT; SKELETON MALFORMATION; TERATOGENICITY; TOXICITY;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BLOOD PROTEINS; CYCLOOXYGENASE INHIBITORS; EMBRYO LOSS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; MATERNAL EXPOSURE; OSTEOGENESIS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; RATS, WISTAR; UREA;

RATTUS;

EID: 67650632799     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2009.04.004     Document Type: Article

References (46)

1. Kalter H. Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established. Neurotoxicol Teratol 25 (2003) 131-282
2. Reuvers M., and Schaefer C. Analgesic and anti-inflammatory drugs. In: Schaefer C., Peters P., and Miller R.E. (Eds). Dugs during pregnancy and lactation. Treatment options and risk assessment (2007), Elsevier, Amsterdam 28-56
3. Ericson A., and Källén B.A. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 15 (2001) 371-375
4. Kozer E., Nikfar S., Costei A., Nulman I., Nikfar S., and Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 187 (2002) 1623-1630
5. Ofori B., Oraichi D., Blais L., Rey E., and Bérard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study. Birth Defects Res B: Dev Reprod Toxicol 77 (2006) 268-279
6. Østensen M., Khamashta M., Lockshin M., Parke A., Brucato A., Carp H., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 8 (2006) 209-228
7. Martínez-Frías M.L., Rodríguez-Pinilla E., and Prieto L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 56 (1997) 241-243
8. Cook J.C., Jacobson C.F., Gao F., Tassinari M.S., Hurtt M.E., and DeSesso J.M. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Birth Defects Res B: Dev Reprod Toxicol. 68 (2003) 5-26
9. Burdan F., Szumilo J., Dudka J., Korobowicz A., and Klepacz R. Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors. Pharmacol Res. 53 (2006) 287-292
10. Burdan F., Szumilo J., Dudka J., Korobowicz A., and Klepacz R. Congenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitors. Braz J Med Biol Res. 39 (2006) 925-934
11. Abe K., Honein M.A., and Moore C.A. Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies. Birth Defects Res A: Clin Mol Teratol. 67 (2003) 911-918
12. Sørensen H.J., Mortensen E.L., Reinisch J.M., and Mednick S.A. Association between prenatal exposure to analgesics and risk of schizophrenia. Br J Psychiatry 185 (2004) 366-371
13. In: Briggs G.G., Freeman R., and Yaffe S.J. (Eds). Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 7th ed. (2005), Lippincott Williams & Wilkins, Philadelphia
14. Li Z., Ren A., Liu J., Pei L., Zhang L., Guo Z., et al. Maternal flu or fever, medication use, and neural tube defects: a population-based case-control study in Northern China. Birth Defects Res A: Clin Mol Teratol 79 (2007) 295-300
15. In: Evans M.I. (Ed). Reproductive risk and prenatal diagnosis (1992), Appleton & Lange, Norwalk
16. Christian M.S. Test methods for assessing female reproductive and developmental toxicology. In: Hayes A.W. (Ed). Principles and method of toxicology. 4th ed. (2001), Taylor & Francis, Philadelphia 1301-1381
17. Burdan F., Szumilo J., Dudka J., Klepacz R., Blaszczak M., Solecki M., et al. Morphological studies in modern teratological investigations. Folia Morphol 64 (2005) 1-8
18. Burdan F. Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats. Birth Defects Res B: Dev Reprod Toxicol. 69 (2004) 321-330
19. Burdan F., Szumilo J., Klepacz R., Korobowicz A., and Klepacz R. Gastrointestinal and hepatic toxicity of selective and nonselective cyclooxygenase-2 inhibitors in pregnant and nonpregnant rats. Pharmacol Res 50 (2004) 534-544
20. Burdan F. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in rats-DFU and piroxicam study. Toxicology 11 (2005) 12-25
21. Burdan F., Szumilo J., Marzec B., Klepacz R., and Dudka J. Skeletal developmental effects of selective and nonselective cyclooxygenase-2 inhibitors administered through organogenesis and fetogenesis in Wistar CRL:(WI)WUBR rats. Toxicology 216 (2005) 204-223
22. Burdan F., Rozylo-Kalinowska I., Szumilo J., Dudka J., and Klepacz R. Cyclooxygenase inhibitors affect bone mineralization in rat fetuses. Cells Tissues Organs 187 (2008) 221-232
23. DevTox. http://www.DevTox.org [last access 24.02.09].
24. PDR Physicians' desk reference. 52 ed. Montvale: Medical Economics Company; 1998. p. 1536-45, 2056-2958, 2179-81
25. In: Tilon R., Balows A., Hohnadel D., and Reiss R. (Eds). Clinical laboratory medicine (1992), Mosby, St. Louis
26. McEvoy T.G., Robinson J.J., Aitken R.P., Findlay P.A., and Robertson I.S. Dietary excesses of urea influence the viability and metabolism of preimplantation sheep embryos and may affect fetal growth among survivors. Anim Reprod Sci 47 (1997) 71-90
27. Campanile G., Neglia G., Di Palo R., Gasparrini B., Pacelli C., D'Occhio M.J., et al. Relationship of body condition score and blood urea and ammonia to pregnancy in Italian Mediterranean buffaloes. Reprod Nutr Dev 46 (2006) 57-62
28. Rhoads M.L., Rhoads R.P., Gilbert R.O., Toole R., and Butler W.R. Detrimental effects of high plasma urea nitrogen levels on viability of embryos from lactating dairy cows. Anim Reprod Sci 91 (2006) 1-10
29. Jackson A.A., Dunn R.L., Marchand M.C., and Langley-Evans S.C. Increased systolic blood pressure in rats induced by a maternal low-protein diet is reversed by dietary supplementation with glycine. Clin Sci (Lond) 103 (2002) 633-639
30. Sato K., Chatani F., Ito K., and Kito G. Characterization of the high sensitivity of rabbits to the effects of TCV-116, an angiotensin II receptor antagonist. Fundam Appl Toxicol 35 (1997) 49-54
31. Preece M.A., and Green A. Pregnancy and inherited metabolic disorders: maternal and fetal complications. Ann Clin Biochem 39 (2002) 444-455
32. Burdan F., Szumilo J., Dudka J., Szumiło M., Korobowicz A., Chatterjee S., et al. Association of maternal pancreatic function and fetal growth in rats treated with DFU, a selective cyclooxygenase-2 inhibitor. Folia Morphol 66 (2007) 172-180
33. Adams S.S., Bough R.G., Cliffe E.E., Lessel B., and Mills R.F. Absorption, distribution and toxicity of ibuprofen. Toxicol Appl Pharmacol 15 (1969) 310-330
34. Nishimura K., Fukagawa S., and Shigematsu K. Teratogenicity study of 1-methyl-5-ptoluoylpyrrole-2-acetate sodium dihydrate (tolmentin sodium) in rabbits. Iykuhin Kenkyu 8 (1977) 158-164
35. Ono M., Hoshida F., Nagase M., and Asami K. Reproductive studies of ibuprofen by rectal administration. (2) Teratogenicity study in rats. Oyo Yakuri 24 (1982) 531-538
36. Ono M., Ogawa Y., Ogihara K., Nagase M., and Asami K. Reproduction studies of ibuprofen by rectal administration. (1) Fertility study in rats. Oyo Yakuri 24 (1982) 467-473
37. Gupta I., Thmas K.J., Datta H., and Mathur V.S. Effect of ibuprofen and naproxen on implantation and pregnancy in rat. Ind J Exp Biol 22 (1984) 282-283
38. Perraud J., Stadler J., Kessedjian M.J., and Monro A.M. Reproductive studies with the anti-inflammatory agent, piroxicam: modification of classical protocols. Toxicology 30 (1984) 59-63
39. Golovanova I.V., Skosyreva A.M., Sharova S.A., and Guskova T.A. Tolerance of some nonsteroidal anti-inflammatory drugs by experimental animals in pregnancy. Farmakol Toksikol 48 (1985) 66-69
40. Cappon G.D., Fleeman T.L., Cook J.C., and Hurtt M.E. Combined treatment potentiates the developmental toxicity of ibuprofen and acetazolamide in rats. Drug Chem Toxicol 28 (2005) 409-421
41. Khera K.S. Maternal toxicity: a possible etiological factor in embryo-fetal deaths and fetal malformations of rodent-rabbit species. Teratology 31 (1985) 129-153
42. Carney E.W., and Kimmel C.A. Interpretation of skeletal variations for human risk assessment: delayed ossification and wavy ribs. Birth Defects Res B: Dev Reprod Toxicol 80 (2007) 473-496
43. Chahoud I., Ligensa A., Dietzel L., and Faqi A.S. Correlation between maternal toxicity and embryo/fetal effects. Reprod Toxicol 13 (1999) 375-381
44. Chahoud I., and Paumgartten F.J.R. Relationship between fetal body weight of Wistar rats at term and the extent of skeletal ossification. Braz J Med Biol Res 38 (2005) 565-575
45. Shaw G.M., Todoroff K., Velie E.M., and Lammer E.J. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 57 (1998) 1-7
46. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61 (2004) 774-780